human MIRN92 microRNA

highly expressed in endothelial cells and controls the growth of new blood vessels (angiogenesis)

Also Known As:

MIRN92 microRNA, human; MIRN9 microRNA, human; MIRN9-1 microRNA, human; MIRN92A2 microRNA, human; MIRN92a microRNA, human; MIRN92b microRNA, human; MicroRNA-92b, human; hsa-mir-9; hsa-mir-9-5p; hsa-mir-92; hsa-mir-92a microRNA; miR 9-3p, human; miR-9, human; miR-9.2, human; miR-92, human; miR-92a, human; miR-92a-3p, human; miR-92b, human; miR-92b-3p, human; miRNA 92a, human; miRNA-92a, human; miRNA9-1, human; miRNA9-3, human; miRNA92a, human; microRNA 9-3p, human; microRNA-9, human; microRNA-92, human; microRNA-92a, human

Networked: 17 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleic Acids: 11752
  - RNA: 69704
    - Untranslated RNA: 2850
      - Small Untranslated RNA: 566
        MicroRNAs: 67298
        human MIRN92 microRNA: 17
    - Antisense RNA: 1599
      - MicroRNAs: 67298
        human MIRN92 microRNA: 17
- Antisense Elements (Genetics): 31
  - Antisense RNA: 1599
    - MicroRNAs: 67298
      - human MIRN92 microRNA: 17

Experts

1.	Ben-Hamo, Rotem: 3 articles (04/2016 - 11/2011)
2.	Efroni, Sol: 3 articles (04/2016 - 11/2011)
3.	Lu, Xiao: 1 article (02/2022)
4.	Sun, Sibo: 1 article (02/2022)
5.	Wang, Kai: 1 article (02/2022)
6.	Wang, Yu: 1 article (02/2022)
7.	Wu, Jianqing: 1 article (02/2022)
8.	Wu, Shuangshuang: 1 article (02/2022)
9.	Xu, Jiali: 1 article (02/2022)
10.	Zhang, Mingjiong: 1 article (02/2022)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2021 - "Moreover, the cell proliferation was seen in a decreased trend while the cell apoptosis increased in the hsa-miR-9-5p group following radiation therapy hsa-miR-9-5p also showed a significant inhibitory effect on the growth of tumor in vivo with radiation therapy. " 10/21/2010 - "Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma." 10/21/2010 - "In this study, we show that two genes encoding for hsa-miR-9 are significantly hypermethylated in ccRCC tumors compared with adjacent normal tissues (P-value <0.001 for both miR-9-1 and miR-9-3) resulting in decreased expression, and that the methylation of these genes was more significant in DNA obtained from the primary tumor for patients who developed a recurrence (P-value: 0.012 and 0.009 for miR-9-1 and miR-9-3, respectively) than in tumors from nonrecurrent patients. " 01/01/2022 - "According to the findings of this review, indeed, the following attributes would be important variables for the early diagnosis of thyroid disease: clinical stage, marital status, histological type, age, nerve injury symptom, economic income, surgery type [the quality of life 3 months after thyroid cancer surgery]; tumor diameter, symptoms, extrathyroidal extension [the local recurrence of differentiated thyroid carcinoma]; RNA feasures including ADD3-AS1 (downregulation), MIR100HG (downregulation), FAM95C (downregulation), MORC2-AS1 (downregulation), LINC00506 (downregulation), ST7-AS1 (downregulation), LOC339059 (downregulation), MIR181A2HG (upregulation), FAM181A-AS1 (downregulation), LBX2-AS1 (upregulation), BLACAT1 (upregulation), hsa-miR-9-5p (downregulation), hsa-miR-146b-3p (upregulation), hsa-miR-199b-5p (downregulation), hsa-miR-4709-3p (upregulation), hsa-miR-34a-5p (upregulation), hsa-miR-214-3p (downregulation) [papillary thyroid carcinoma]; gut microbiota RNA features such as veillonella, paraprevotella, neisseria, rheinheimera [hypothyroidism]; and ultrasound features, i.e., wreath-shaped feature, micro-calcification, strain ratio [the malignancy of thyroid nodules]."
2.	Chordoma 07/19/2023 - "The study aims to investigate the roles of LINC01116 and hsa-miR-9-5p (miR-9-5p) and fathom their interaction in chordoma. "
3.	Nasopharyngeal Carcinoma 01/01/2021 - "hsa-miR-9-5p Down-Regulates HK2 and Confers Radiosensitivity to Nasopharyngeal Carcinoma." 01/01/2021 - "This study was designed to explore the effects of hsa-miR-9-5p on radiotherapy sensitivity of nasopharyngeal carcinoma (NPC) by targeting hexokinase 2 (HK2). "
4.	Glioblastoma (Glioblastoma Multiforme) 01/01/2012 - "Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression." 11/28/2011 - "Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression." 04/26/2016 - "hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements."
5.	Leukemia 01/01/2023 - "Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβ Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide." 01/01/2020 - "hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide."

Related Drugs and Biologics

1.	Hexokinase
2.	DNA (Deoxyribonucleic Acid)
3.	MicroRNAs (MicroRNA)
4.	Etoposide (VP 16)
5.	Mitogen-Activated Protein Kinase 14
6.	RNA (Ribonucleic Acid)
7.	Type I DNA Topoisomerases (Topoisomerase I)

Related Therapies and Procedures

1.	Radiotherapy